| Date Filed | Type | Description |
| 04/10/2018 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 0% stake in Bioverativ Inc. |
| 03/19/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/08/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/08/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/08/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/08/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/08/2018 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 03/08/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
| 03/08/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/08/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/06/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for SandRidge Energy, BIOVERATIV INC, Ultra Clean, The Mosaic, Papa John's International, and Chegg — Fundamental Analysis, Key Performance Indications |
| 02/28/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/27/2018 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 7.1% stake in Bioverativ Inc. |
| 02/23/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/23/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/20/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/20/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/14/2018 |
SC 13G/A
| HealthCor Management, L.P. reports a 3.5% stake in Bioverativ, Inc. |
| 02/14/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 02/13/2018 |
BW
| Bioverativ Reports Fourth Quarter and Full Year 2017 Performance |
| 02/09/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/09/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/08/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/08/2018 |
SC 13G
| VANGUARD GROUP INC reports a 8.5% stake in Bioverativ Inc |
| 02/08/2018 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 02/07/2018 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 02/06/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/22/2018 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 01/22/2018 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/22/2018 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 01/16/2018 |
BW
| Bioverativ to Report Fourth Quarter and Year-End 2017 Financial Results on February 13, 2018 |
| 01/09/2018 |
SC 13G
| BlackRock Inc. reports a 10% stake in BIOVERATIV INC |
| 01/02/2018 |
BW
| Bioverativ to Present at the 2018 J.P. Morgan Healthcare Conference |
| 10/27/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
|